Role of unfolded protein response and COL8A2 in Fuchs corneal dystrophy
Role of unfolded protein response and COL8A2 in Fuchs corneal dystrophy
批准号:
7987111
负责人:
ALBERT S JUN
金额:
$41.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-09-01 至 2015-08-31
关键词:
AffectAgeAge-MonthsAllelesAmino AcidsAnimalsApoptosisBasement membraneBlindnessCaspaseCell Culture TechniquesCell DeathCell LineCell ShapeCell physiologyCellsCellular MorphologyCellular StressCessation of lifeChronicCollagenCorneaCorneal DiseasesCorneal EndotheliumCorneal dystrophyDataDescemet&aposs membraneDiseaseEndothelial CellsEndotheliumEventExhibitsFunctional disorderGene TargetingGenesGenetic TranscriptionGlutamineGoalsHumanHydration statusImmunofluorescence ImmunologicIn VitroInduction of ApoptosisInheritedKeratoplastyKnock-in MouseKnowledgeLaboratoriesLeucineLinkLysineMediatingMissense MutationModelingMusMutant Strains MiceMutationNational Eye InstituteOperative Surgical ProceduresPAWR proteinPathogenesisPathologicPathway interactionsPatientsPhenotypePhysiologicalPopulationPositioning AttributeProteinsResearchRisk FactorsRoleSpecimenStagingStaining methodStainsStressSurfaceTestingTranslationsTryptophanTunicamycinUltraviolet RaysUp-RegulationWorkcaspase 12clinically relevantdensityenvironmental stressorgenetic risk factorimprovedin vivoinsightmetermodifiable riskmutantnovelprotein foldingprotein misfoldingpublic health relevanceresponseresponse markertool
中文摘要
描述(申请人提供):Fuchs内皮角膜营养不良(FECD)是美国人群中最常见和临床相关的遗传性角膜疾病,也是2007年角膜移植的第三大原因。FECD的原因是角膜内皮细胞的慢性丢失,这些内皮细胞排列在角膜内表面,维持角膜透明所需的生理水合。在某些情况下,FECD是由α2胶原蛋白VIII(COL8A2)基因的错义突变引起的。由于只有在角膜移植时获得的终末期角膜可用于研究,因此对FECD的发病机制知之甚少。有限的研究表明,晚期FECD角膜的内皮细胞正在发生凋亡,尽管导致凋亡的机制尚不清楚。因此,动物和细胞培养模型将是阐明FECD中导致内皮细胞凋亡的早期事件的宝贵工具。我们的初步工作包括:1)寻找FECD患者角膜内皮未折叠蛋白反应(UPR)的标志物。正确的蛋白质折叠对细胞的正常功能至关重要。UPR是一种高度保守的、广泛的细胞反应,由过量的错误折叠蛋白诱导。最初,UPR的功能是通过选择性地改变转录和翻译来缓解未折叠蛋白质的压力。如果蛋白质折叠需求和折叠能力保持不平衡,UPR会诱导细胞发生凋亡。此外,2)我们开发了两个基因靶向敲入小鼠品系,它们具有已知的导致人类FECD的不同COL8A2突变。初步结果显示,角膜内皮基底膜的病理变化与人类FECD角膜的病理变化非常相似。这项应用的总体假设是“角膜内皮细胞表达COL8A2突变激活了未折叠的蛋白反应,导致内皮细胞死亡。”获得具有相关病理表型的COL8A2 FECD敲入小鼠为检验这一假说提供了一个宝贵的机会,具体如下:AIM 1将评估COL8A2突变小鼠的角膜内皮细胞凋亡,并将更详细地表征与人类FECD角膜相似的角膜内皮和内皮基底膜的病理变化。目的研究COL8A2突变小鼠角膜和培养的角膜内皮细胞系中UPR的活性。目的3将评估紫外线(已知的UPR诱导物和角膜内皮的环境应激源)对角膜和培养的COL8A2突变小鼠角膜内皮细胞株UPR激活的协同作用。这项建议试图利用COL8A2 FECD突变小鼠和角膜内皮细胞系,在主要的细胞应激途径UPR和由COL8A2的FECD突变导致的角膜内皮细胞凋亡之间建立新的机制联系。这种联系的建立将代表着国家眼科研究所在改善遗传角膜疾病的知识和治疗方面的目标方面取得的重大进展。
公共卫生意义:Fuchs内皮性角膜营养不良(FECD)是一种常见疾病,由于角膜内层内的角膜内皮细胞死亡而导致角膜透明度降低,从而导致视力丧失(Borboli 2002)。FECD影响了大约0.6%的美国人口(Krachmer,1978),是美国角膜移植手术的第三大原因(Van Meter,2007)。本研究的目的是探讨未折叠蛋白反应在FECD中导致内皮细胞死亡的作用,这是一个主要的细胞应激途径。
英文摘要
DESCRIPTION (provided by applicant): Fuchs endothelial corneal dystrophy (FECD) is the most common and clinically relevant inherited corneal disease in the US population and the third leading cause of corneal transplants in 2007. FECD results from chronic loss of corneal endothelial cells which line the inner surface of the cornea and maintain physiologic hydration necessary for corneal clarity. In some cases, FECD is caused by missense mutations in the alpha 2 collagen VIII (COL8A2) gene. Very little is known about the pathogenesis of FECD due to the fact that only end stage corneas obtained at corneal transplant are available for study. Limited work indicates that apoptosis is occurring in endothelial cells from advanced FECD corneas, although the mechanisms leading to apoptosis are poorly understood. Thus, animal and cell culture models would be invaluable tools to elucidate early events leading to endothelial cell apoptosis in FECD. Our preliminary work includes: 1) identification of markers for the unfolded protein response (UPR) in the endothelium of FECD patient corneas. Proper protein folding is critical for normal function of the cell. The UPR is a highly conserved, broad ranging cellular response induced by an excess of misfolded proteins. Initially, the UPR functions to relieve stress of unfolded proteins through selective alterations in transcription and translation. If protein folding demand and capacity remain unbalanced, the UPR induces cells to undergo apoptosis. In addition, 2) we have developed two gene targeted knock-in mouse lines with different COL8A2 mutations known to cause FECD in humans. Preliminary results show pathologic changes in the basement membrane of the corneal endothelium which are highly similar to those seen in human FECD corneas. The overall hypothesis of this application is that "corneal endothelial cell expression of COL8A2 mutations activates the unfolded protein response and results in endothelial cell death." The availability of COL8A2 FECD knock-in mice with a relevant pathologic phenotype provides an invaluable opportunity to test this hypothesis as follows: Aim 1 will assess COL8A2 mutant mice for corneal endothelial cell apoptosis and will characterize in greater detail pathologic changes in corneal endothelium and the endothelial basement membrane comparable to human FECD corneas. Aim 2 will assess for UPR activation in corneas and cultured corneal endothelial cell lines from COL8A2 mutant mice. Aim 3 will assess for synergistic effects of UV light (a known inducer of the UPR and environmental stressor for the corneal endothelium) on UPR activation in corneas and cultured corneal endothelial cell lines from COL8A2 mutant mice. This proposal seeks to use COL8A2 FECD mutant mice and corneal endothelial cell lines to establish a novel mechanistic link between the UPR, a major cell stress pathway, and corneal endothelial cell apoptosis resulting from FECD mutations in COL8A2. The establishment of such a link would represent a major advance in the National Eye Institute's goals of improving knowledge and treatment of inherited corneal diseases.
PUBLIC HEALTH RELEVANCE: Fuchs endothelial corneal dystrophy (FECD) is a common disease which causes loss of vision from decreased corneal clarity due to death of corneal endothelial cells lining the inner layer of the cornea (Borboli 2002). FECD affects approximately 0.6% of the US population (Krachmer 1978) and is the third leading cause of corneal transplant surgery in the US (Van Meter 2007). The purpose of this study is to investigate the role of the unfolded protein response, a major cell stress pathway, in causing endothelial cell death in FECD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pathogenesis and CRISPR/Cas9 Correction of TCF4 Expansion in Fuchs Dystrophy
-
批准号:9018954
-
项目类别:
-
资助金额:$24.3万
-
财政年份:2015
-
负责人:ALBERT S JUN
-
依托单位:
Pathogenesis and CRISPR/Cas9 Correction of TCF4 Expansion in Fuchs Dystrophy
-
批准号:9181443
-
项目类别:
-
资助金额:$20.25万
-
财政年份:2015
-
负责人:ALBERT S JUN
-
依托单位:
Role of unfolded protein response and COL8A2 in Fuchs corneal dystrophy
-
批准号:8123246
-
项目类别:
-
资助金额:$39.36万
-
财政年份:2010
-
负责人:ALBERT S JUN
-
依托单位:
Role of unfolded protein response and COL8A2 in Fuchs corneal dystrophy
-
批准号:8303341
-
项目类别:
-
资助金额:$39.36万
-
财政年份:2010
-
负责人:ALBERT S JUN
-
依托单位:
Role of unfolded protein response and COL8A2 in Fuchs corneal dystrophy
-
批准号:8509695
-
项目类别:
-
资助金额:$37.39万
-
财政年份:2010
-
负责人:ALBERT S JUN
-
依托单位:
Role of Alpha 2 Collagen VIII in Fuchs Corneal Dystrophy
-
批准号:7087724
-
项目类别:
-
资助金额:$22.97万
-
财政年份:2004
-
负责人:ALBERT S JUN
-
依托单位:
Role of Alpha 2 Collagen VIII in Fuchs Corneal Dystrophy
-
批准号:6915210
-
项目类别:
-
资助金额:$22.38万
-
财政年份:2004
-
负责人:ALBERT S JUN
-
依托单位:
Role of Alpha 2 Collagen VIII in Fuchs Corneal Dystrophy
-
批准号:7434325
-
项目类别:
-
资助金额:$24.2万
-
财政年份:2004
-
负责人:ALBERT S JUN
-
依托单位:
Role of Alpha 2 Collagen VIII in Fuchs Corneal Dystrophy
-
批准号:6765443
-
项目类别:
-
资助金额:$21.66万
-
财政年份:2004
-
负责人:ALBERT S JUN
-
依托单位:
Role of Alpha 2 Collagen VIII in Fuchs Corneal Dystrophy
-
批准号:7251453
-
项目类别:
-
资助金额:$23.58万
-
财政年份:2004
-
负责人:ALBERT S JUN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
-
批准号:82505677
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:吕雨霏
-
依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
-
批准号:82574874
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2025
-
负责人:刘天华
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位: